Driving Excellence in Ophthalmic Research.

Learn how our people, values, and journey shape everything we do.

Who We Are

At iuvo, our vision is clear: to accelerate the development of life-changing eye therapies and advance patient access to breakthrough vision treatments. By concentrating exclusively on ophthalmic clinical research, we help bring innovation from the lab to the clinic — faster, smarter, and more efficiently — improving sight and quality of life for patients around the world.

The name iuvo comes from the Latin word meaning “to help” or “to aid.” That purpose is at the heart of everything we do — guiding how we serve our clients, how we support clinical study investigators, and why we’re passionate about advancing outcomes for people living with visual impairments and diseases.

Vision

We aspire to be the premier ophthalmic clinical research provider working with innovators to improve the quality of life for patients and practitioners around the world.

Mission

To provide excellence in ophthalmic clinical trial management and associated regulatory services to enhance the health care experiences and outcomes for patients and providers.

Values

Our core values guide how we work with sponsors, clinical sites, and colleagues every day:

We strive to collaborate with our clients to help them conduct successful projects. We take our clients’ time and budget seriously. As a service organization, our client’s success is our success.

We strive to allow ourselves and others to communicate professionally, openly and without fear of reprisal.
We strive to review processes critically and constructively on an ongoing basis. Each person at iuvo is encouraged to participate in education programs to stay current in the field.

We strive to create a positive balance between our personal and
professional lives for the betterment of both.

We strive to treat our clients and each other as we wish to be treated, and strive to fix systems, not people.
We strive to perform project activities and conduct business in an ethical and quality manner.
We strive to do what we say we are going to do, when we say we will do it. We hold ourselves accountable for meeting our commitments and take ownership of the results.

Our Story

Founded in 2015 by former Bausch + Lomb executives Ben Burton and Mary Richardson, iuvo (Latin for “to help or aid”) began with a vision to deliver an exceptional blend of scientific expertise and white-glove service to companies developing new
therapies.

Key milestones in our journey:

2015
iuvo was formed to provide
testing and consulting services to the
pharmaceutical and medical device industry
2018
Acquired Oculos Clinical Research, expanding
our ophthalmic capabilities

2012 Oculos Clinical Research founded as a clinical CRO with expertise in ophthalmology

2022
Partnered with Ampersand Capital Partners
to accelerate growth
2024
Acquired Promedica International, enhancing
our U.S. operations and medical device trial
expertise
2025
Divested our lab and consulting division to
sharpen our sole focus on ophthalmic
clinical research
Today
iuvo is a trusted CRO partner to
pharmaceutical, biotech, and device
companies worldwide. From early feasibility to
global Phase III trials, we offer deep domain
expertise, nimble operations, and a
commitment to getting sight-saving
innovations into the hands of patients.
2012 Oculos Clinical Research founded as a clinical CRO with expertise in ophthalmology
1985 Promedica International founded as a clinical CRO with expertise in ophthalmology

Our Story

Founded in 2015 by former Bausch + Lomb executives Ben Burton and Mary Richardson, iuvo (Latin for “to help or aid”) began with a vision to deliver an exceptional blend of scientific expertise and white-glove service to companies developing new
therapies.

Key milestones in our journey:

2015
iuvo was formed to provide testing and consulting services to the pharmaceutical and medical device industry
2018
Acquired Oculos Clinical Research, expanding our ophthalmic capabilities

2012 Oculos Clinical Research founded as a clinical CRO with expertise in ophthalmology

2022
Partnered with Ampersand Capital Partners to accelerate growth
2024
Acquired Promedica International, enhancing our U.S. operations and medical device trial expertise
2025
Divested our lab and consulting division to sharpen our sole focus on ophthalmic clinical research
Today
iuvo is a trusted CRO partner to pharmaceutical, biotech, and device companies worldwide. From early feasibility to global Phase III trials, we offer deep domain expertise, nimble operations, and a commitment to getting sight-saving innovations into the hands of patients.
2012 Oculos Clinical Research founded as a clinical CRO with expertise in ophthalmology
1985 Promedica International founded as a clinical CRO with expertise in ophthalmology

Meet the Leaders
Behind the Mission

Our people are the heart of our success. With hundreds of years of combined experience in ophthalmology, our team includes clinical operations leaders, therapeutic experts, regulatory strategists, board-certified ophthalmologists, and data science professionals — all working together to advance eye care innovation.

Expertise That Moves You Forward

Partner with an ophthalmic contract research organization committed to accelerating your clinical trial success.